| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143117 | Lung Cancer | 2009 | 5 Pages |
Abstract
Our results suggest that chemotherapy can be used to increase survival of patients treated with cranial irradiation for newly diagnosed NSCLC with synchronous BM. However, systemic chemotherapy should be carefully considered according to the patient's prognostic condition. Especially, patients with good performance status and limited number of BM may be good candidates for systemic chemotherapy after cranial irradiation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jung Han Kim, Hyeong Su Kim, Jung Hye Kwon, Sarah Park, Ho Young Kim, Joo Young Jung, Hyo Jung Kim, Hun Ho Song, Gyeong-Won Lee, Soon Il Lee, Soo Jung Gong, Jung-Ae Lee, Kyoung Ju Kim, Dae Young Zang,